We Research
We Innovate
We Improve Lives

We promote research, prevention, and innovation to improve the treatment and rehabilitation of patients with cerebrovascular diseases.

More Support our Work

1 in 100.000

people affected
by AVM

58%

risk of bleeding
up to age 35

strokes in young people
are associated with AVM

2026

Founding year

The three pillars of our mission

Development of innovative research approaches to better understand and treat neurovascular diseases.

Informing and educating the public about prevention, early diagnosis, and the reduction of risk factors.

Holistic care and support for patients to facilitate their swift reintegration and enable them to live with dignity.

Arteriovenous malformation (AVM) is a rare but serious vascular anomaly that can cause cerebral hemorrhage, neurological deficits, and disability.

23.10.2026

View all Members

Dr. Spyros KaradimasPresident

Dr. Christopher KellnerMember

Dr. George StranjalisMember

Dr. Georgios TsivgoulisMember

Dr. George DangasMember

Dr. Konstantinos MargetisMember

Dr. Aristotelis KalyvasMember

Dr. Nikolaos ScarmeasAlternate Member

Dr. Stamatios LerakisAlternate Member

DONATIONS